ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $2,930,000 | +81.9% | 47,423 | +14.4% | 0.05% | +73.3% |
Q3 2014 | $1,611,000 | +31.3% | 41,463 | +16.6% | 0.03% | +36.4% |
Q2 2014 | $1,227,000 | -29.3% | 35,561 | -11.5% | 0.02% | -33.3% |
Q1 2014 | $1,735,000 | +71.4% | 40,175 | +57.8% | 0.03% | +94.1% |
Q4 2013 | $1,012,000 | +14.2% | 25,461 | +8.0% | 0.02% | 0.0% |
Q3 2013 | $886,000 | +75.4% | 23,565 | +25.4% | 0.02% | +54.5% |
Q2 2013 | $505,000 | – | 18,785 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |